{"doc_id": "PMID-10377075.txt", "sent_id": "S1", "tokens": ["PPARalpha", "activators", "inhibit", "cytokine", "-", "induced", "vascular", "cell", "adhesion", "molecule-1", "expression", "in", "human", "endothelial", "cells", "."], "sentence": "PPARalpha activators inhibit cytokine - induced vascular cell adhesion molecule-1 expression in human endothelial cells .", "event_mentions": [{"id": "E1", "event_type": "Negative_regulation", "trigger": {"text": "inhibit", "start": 2, "end": 2}, "arguments": [{"entity_id": "T21", "text": "induced", "role": "Theme"}]}, {"id": "E2", "event_type": "Positive_regulation", "trigger": {"text": "induced", "start": 5, "end": 5}, "arguments": [{"entity_id": "T22", "text": "expression", "role": "Theme"}]}, {"id": "E3", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 10, "end": 10}, "arguments": [{"entity_id": "T1", "text": "vascular cell adhesion molecule-1", "role": "Theme"}]}], "entity_mentions": [{"id": "T1", "text": "vascular cell adhesion molecule-1", "entity_type": "Protein", "start": 6, "end": 9}, {"id": "T20", "text": "inhibit", "entity_type": "Negative_regulation", "start": 2, "end": 2}, {"id": "T21", "text": "induced", "entity_type": "Positive_regulation", "start": 5, "end": 5}, {"id": "T22", "text": "expression", "entity_type": "Gene_expression", "start": 10, "end": 10}]}
{"doc_id": "PMID-10377075.txt", "sent_id": "", "tokens": ["BACKGROUND", ":", "Adhesion", "molecule", "expression", "on", "the", "endothelial", "cell", "(", "EC", ")", "surface", "is", "critical", "for", "leukocyte", "recruitment", "to", "atherosclerotic", "lesions", "."], "sentence": "BACKGROUND : Adhesion molecule expression on the endothelial cell ( EC ) surface is critical for leukocyte recruitment to atherosclerotic lesions .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMID-10377075.txt", "sent_id": "", "tokens": ["Better", "understanding", "of", "transcriptional", "regulation", "of", "adhesion", "molecules", "in", "ECs", "may", "provide", "important", "insight", "into", "plaque", "formation", "."], "sentence": "Better understanding of transcriptional regulation of adhesion molecules in ECs may provide important insight into plaque formation .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMID-10377075.txt", "sent_id": "S4", "tokens": ["Peroxisome", "proliferator-activated", "receptor-alpha", "(", "PPARalpha", ")", ",", "a", "member", "of", "the", "nuclear", "receptor", "family", ",", "regulates", "gene", "expression", "in", "response", "to", "certain", "fatty", "acids", "and", "fibric", "acid", "derivatives", "."], "sentence": "Peroxisome proliferator-activated receptor-alpha ( PPARalpha ) , a member of the nuclear receptor family , regulates gene expression in response to certain fatty acids and fibric acid derivatives .", "event_mentions": [{"id": "E4", "event_type": "Regulation", "trigger": {"text": "in response to", "start": 18, "end": 20}, "arguments": [{"entity_id": "T3", "text": "PPARalpha", "role": "Theme"}]}], "entity_mentions": [{"id": "T2", "text": "Peroxisome proliferator-activated receptor-alpha", "entity_type": "Protein", "start": 0, "end": 2}, {"id": "T3", "text": "PPARalpha", "entity_type": "Protein", "start": 4, "end": 4}, {"id": "T23", "text": "in response to", "entity_type": "Regulation", "start": 18, "end": 20}]}
{"doc_id": "PMID-10377075.txt", "sent_id": "S5", "tokens": ["The", "present", "study", "investigated", "PPARalpha", "expression", "in", "human", "ECs", "and", "their", "regulation", "of", "vascular", "cell", "adhesion", "molecule-1", "(", "VCAM-1", ")", "."], "sentence": "The present study investigated PPARalpha expression in human ECs and their regulation of vascular cell adhesion molecule-1 ( VCAM-1 ) .", "event_mentions": [{"id": "E5", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 5, "end": 5}, "arguments": [{"entity_id": "T4", "text": "PPARalpha", "role": "Theme"}]}, {"id": "E6", "event_type": "Regulation", "trigger": {"text": "regulation", "start": 11, "end": 11}, "arguments": [{"entity_id": "T6", "text": "VCAM-1", "role": "Theme"}, {"entity_id": "T4", "text": "PPARalpha", "role": "Cause"}]}], "entity_mentions": [{"id": "T4", "text": "PPARalpha", "entity_type": "Protein", "start": 4, "end": 4}, {"id": "T5", "text": "vascular cell adhesion molecule-1", "entity_type": "Protein", "start": 13, "end": 16}, {"id": "T6", "text": "VCAM-1", "entity_type": "Protein", "start": 18, "end": 18}, {"id": "T24", "text": "expression", "entity_type": "Gene_expression", "start": 5, "end": 5}, {"id": "T25", "text": "regulation", "entity_type": "Regulation", "start": 11, "end": 11}]}
{"doc_id": "PMID-10377075.txt", "sent_id": "S6", "tokens": ["METHODS", "AND", "RESULTS", ":", "Immunohistochemistry", "revealed", "that", "human", "carotid", "artery", "ECs", "express", "PPARalpha", "."], "sentence": "METHODS AND RESULTS : Immunohistochemistry revealed that human carotid artery ECs express PPARalpha .", "event_mentions": [{"id": "E7", "event_type": "Gene_expression", "trigger": {"text": "express", "start": 11, "end": 11}, "arguments": [{"entity_id": "T7", "text": "PPARalpha", "role": "Theme"}]}], "entity_mentions": [{"id": "T7", "text": "PPARalpha", "entity_type": "Protein", "start": 12, "end": 12}, {"id": "T26", "text": "express", "entity_type": "Gene_expression", "start": 11, "end": 11}]}
{"doc_id": "PMID-10377075.txt", "sent_id": "S7", "tokens": ["Pretreatment", "of", "cultured", "human", "ECs", "with", "the", "PPARalpha", "activators", "fenofibrate", "or", "WY14643", "inhibited", "TNF-alpha", "-", "induced", "VCAM-1", "in", "a", "time", "-", "and", "concentration", "-", "dependent", "manner", ",", "an", "effect", "not", "seen", "with", "PPARgamma", "activators", "."], "sentence": "Pretreatment of cultured human ECs with the PPARalpha activators fenofibrate or WY14643 inhibited TNF-alpha - induced VCAM-1 in a time - and concentration - dependent manner , an effect not seen with PPARgamma activators .", "event_mentions": [{"id": "E8", "event_type": "Positive_regulation", "trigger": {"text": "activators", "start": 8, "end": 8}, "arguments": [{"entity_id": "T8", "text": "PPARalpha", "role": "Theme"}]}, {"id": "E9", "event_type": "Negative_regulation", "trigger": {"text": "inhibited", "start": 12, "end": 12}, "arguments": [{"entity_id": "T29", "text": "induced", "role": "Theme"}]}, {"id": "E10", "event_type": "Positive_regulation", "trigger": {"text": "induced", "start": 15, "end": 15}, "arguments": [{"entity_id": "T10", "text": "VCAM-1", "role": "Theme"}, {"entity_id": "T9", "text": "TNF-alpha", "role": "Cause"}]}], "entity_mentions": [{"id": "T8", "text": "PPARalpha", "entity_type": "Protein", "start": 7, "end": 7}, {"id": "T9", "text": "TNF-alpha", "entity_type": "Protein", "start": 13, "end": 13}, {"id": "T10", "text": "VCAM-1", "entity_type": "Protein", "start": 16, "end": 16}, {"id": "T11", "text": "PPARgamma", "entity_type": "Protein", "start": 32, "end": 32}, {"id": "T27", "text": "activators", "entity_type": "Positive_regulation", "start": 8, "end": 8}, {"id": "T28", "text": "inhibited", "entity_type": "Negative_regulation", "start": 12, "end": 12}, {"id": "T29", "text": "induced", "entity_type": "Positive_regulation", "start": 15, "end": 15}]}
{"doc_id": "PMID-10377075.txt", "sent_id": "S8", "tokens": ["Both", "PPARalpha", "activators", "decreased", "cytokine", "-", "induced", "VCAM-1", "mRNA", "expression", "without", "altering", "its", "mRNA", "half-life", "."], "sentence": "Both PPARalpha activators decreased cytokine - induced VCAM-1 mRNA expression without altering its mRNA half-life .", "event_mentions": [{"id": "E11", "event_type": "Negative_regulation", "trigger": {"text": "decreased", "start": 3, "end": 3}, "arguments": [{"entity_id": "T31", "text": "induced", "role": "Theme"}]}, {"id": "E12", "event_type": "Positive_regulation", "trigger": {"text": "induced", "start": 6, "end": 6}, "arguments": [{"entity_id": "T32", "text": "mRNA expression", "role": "Theme"}]}, {"id": "E13", "event_type": "Transcription", "trigger": {"text": "mRNA expression", "start": 8, "end": 9}, "arguments": [{"entity_id": "T13", "text": "VCAM-1", "role": "Theme"}]}, {"id": "E14", "event_type": "Regulation", "trigger": {"text": "altering", "start": 11, "end": 11}, "arguments": [{"entity_id": "T13", "text": "VCAM-1", "role": "Theme"}]}], "entity_mentions": [{"id": "T12", "text": "PPARalpha", "entity_type": "Protein", "start": 1, "end": 1}, {"id": "T13", "text": "VCAM-1", "entity_type": "Protein", "start": 7, "end": 7}, {"id": "T30", "text": "decreased", "entity_type": "Negative_regulation", "start": 3, "end": 3}, {"id": "T31", "text": "induced", "entity_type": "Positive_regulation", "start": 6, "end": 6}, {"id": "T32", "text": "mRNA expression", "entity_type": "Transcription", "start": 8, "end": 9}, {"id": "T33", "text": "altering", "entity_type": "Regulation", "start": 11, "end": 11}]}
{"doc_id": "PMID-10377075.txt", "sent_id": "S9", "tokens": ["Transient", "transfection", "of", "deletional", "VCAM-1", "promoter", "constructs", "and", "electrophoretic", "mobility", "shift", "assays", "suggest", "that", "fenofibrate", "inhibits", "VCAM-1", "transcription", "in", "part", "by", "inhibiting", "NF-kappaB", "."], "sentence": "Transient transfection of deletional VCAM-1 promoter constructs and electrophoretic mobility shift assays suggest that fenofibrate inhibits VCAM-1 transcription in part by inhibiting NF-kappaB .", "event_mentions": [{"id": "E15", "event_type": "Transcription", "trigger": {"text": "transcription", "start": 17, "end": 17}, "arguments": [{"entity_id": "T15", "text": "VCAM-1", "role": "Theme"}]}], "entity_mentions": [{"id": "T14", "text": "VCAM-1", "entity_type": "Protein", "start": 4, "end": 4}, {"id": "T15", "text": "VCAM-1", "entity_type": "Protein", "start": 16, "end": 16}, {"id": "T34", "text": "transcription", "entity_type": "Transcription", "start": 17, "end": 17}]}
{"doc_id": "PMID-10377075.txt", "sent_id": "S10", "tokens": ["Finally", ",", "PPARalpha", "activators", "significantly", "reduced", "adhesion", "of", "U937", "cells", "to", "cultured", "human", "ECs", "."], "sentence": "Finally , PPARalpha activators significantly reduced adhesion of U937 cells to cultured human ECs .", "event_mentions": [], "entity_mentions": [{"id": "T16", "text": "PPARalpha", "entity_type": "Protein", "start": 2, "end": 2}]}
{"doc_id": "PMID-10377075.txt", "sent_id": "S11", "tokens": ["CONCLUSIONS", ":", "Human", "ECs", "express", "PPARalpha", ",", "a", "potentially", "important", "regulator", "of", "atherogenesis", "through", "its", "transcriptional", "control", "of", "VCAM-1", "gene", "expression", "."], "sentence": "CONCLUSIONS : Human ECs express PPARalpha , a potentially important regulator of atherogenesis through its transcriptional control of VCAM-1 gene expression .", "event_mentions": [{"id": "E16", "event_type": "Gene_expression", "trigger": {"text": "express", "start": 4, "end": 4}, "arguments": [{"entity_id": "T17", "text": "PPARalpha", "role": "Theme"}]}, {"id": "E17", "event_type": "Regulation", "trigger": {"text": "transcriptional control", "start": 15, "end": 16}, "arguments": [{"entity_id": "T37", "text": "expression", "role": "Theme"}, {"entity_id": "T17", "text": "PPARalpha", "role": "Cause"}]}, {"id": "E18", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 20, "end": 20}, "arguments": [{"entity_id": "T18", "text": "VCAM-1", "role": "Theme"}]}], "entity_mentions": [{"id": "T17", "text": "PPARalpha", "entity_type": "Protein", "start": 5, "end": 5}, {"id": "T18", "text": "VCAM-1", "entity_type": "Protein", "start": 18, "end": 18}, {"id": "T35", "text": "express", "entity_type": "Gene_expression", "start": 4, "end": 4}, {"id": "T36", "text": "transcriptional control", "entity_type": "Regulation", "start": 15, "end": 16}, {"id": "T37", "text": "expression", "entity_type": "Gene_expression", "start": 20, "end": 20}]}
{"doc_id": "PMID-10377075.txt", "sent_id": "S12", "tokens": ["Such", "findings", "also", "have", "implications", "regarding", "the", "clinical", "use", "of", "lipid-lowering", "agents", ",", "like", "fibric", "acids", ",", "which", "can", "activate", "PPARalpha", "."], "sentence": "Such findings also have implications regarding the clinical use of lipid-lowering agents , like fibric acids , which can activate PPARalpha .", "event_mentions": [{"id": "E19", "event_type": "Positive_regulation", "trigger": {"text": "activate", "start": 19, "end": 19}, "arguments": [{"entity_id": "T19", "text": "PPARalpha", "role": "Theme"}]}], "entity_mentions": [{"id": "T19", "text": "PPARalpha", "entity_type": "Protein", "start": 20, "end": 20}, {"id": "T38", "text": "activate", "entity_type": "Positive_regulation", "start": 19, "end": 19}]}
